--- title: Blog - Launch and Market Access trends in pharma | TRiBECA Knowledge | London | launch readiness (2) description: launch readiness | Keep up to date with the latest launch, market access and tender management trends in the pharmaceutical and biotech sector. (2) --- ## Featured Post ### [6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges) - ![](https://www.tribecaknowledge.com/hubfs/website-2022/blog-author.png) Andre Moa - ![](https://www.tribecaknowledge.com/hubfs/website-2022/blog-date.png) 21 Jan 2025 - ![](https://www.tribecaknowledge.com/hubfs/website-2022/blog-length.png) 21 minute read Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good. [Read more](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges) ## Latest posts ### [How the coronavirus crisis could affect your new drug launch](https://www.tribecaknowledge.com/blog/how-the-coronavirus-crisis-could-hit-your-new-drug-launch) The coronavirus is forcing pharma to think creatively about remote working in a constrained environment. Digital technology will be crucial in softening the pandemic’s multiple impacts on drug launches. [Read more](https://www.tribecaknowledge.com/blog/how-the-coronavirus-crisis-could-hit-your-new-drug-launch) ### [From Volume to Value: Strategising launch readiness in 2020](https://www.tribecaknowledge.com/blog/from-volume-to-value-strategising-launch-readiness-in-2020) The pharmaceutical market in 2020 is more about product diversity, breakthrough science and new therapeutic targets than spectacular launch volumes. [Read more](https://www.tribecaknowledge.com/blog/from-volume-to-value-strategising-launch-readiness-in-2020) ### [5 Pharma Trends for 2020: Counting the value and cost of innovation](https://www.tribecaknowledge.com/blog/5-pharma-trends-for-2020) The pharmaceutical market in 2020 is more about product diversity, breakthrough science and new therapeutic targets than spectacular launch volumes. [Read more](https://www.tribecaknowledge.com/blog/5-pharma-trends-for-2020) ### [2019 New Drug Approvals And Updates: The Year In Review](https://www.tribecaknowledge.com/blog/2019-new-drug-approvals-and-updates-the-year-in-review) US and EU drug approvals for 2019 may be lagging last year’s peaks, but innovation and blockbuster potential are far from exhausted. [Read more](https://www.tribecaknowledge.com/blog/2019-new-drug-approvals-and-updates-the-year-in-review) ### [How digital transformation can streamline your new pharma product launch](https://www.tribecaknowledge.com/blog/how-digital-transformation-can-streamline-your-new-pharma-product-launch) Digital transformation has brought benefits but also challenges for pharma launches. With the right software, launch teams can ensure digital works to their advantage. [Read more](https://www.tribecaknowledge.com/blog/how-digital-transformation-can-streamline-your-new-pharma-product-launch) ### [How to stay on top of your global market access challenges](https://www.tribecaknowledge.com/blog/how-to-stay-on-top-of-your-global-market-access-challenges) The right software will help you turn an array of market access challenges for new medicines into competitive differentiation that drives launch success. [Read more](https://www.tribecaknowledge.com/blog/how-to-stay-on-top-of-your-global-market-access-challenges) ### [How to gain full visibility of launch readiness across countries worldwide](https://www.tribecaknowledge.com/blog/how-to-gain-full-visibility-of-launch-readiness-across-countries-worldwide) In an increasingly networked pharmaceutical market, you can head off access challenges with software that gives full visibility of launch readiness worldwide [Read more](https://www.tribecaknowledge.com/blog/how-to-gain-full-visibility-of-launch-readiness-across-countries-worldwide) ### [How to keep your global and country launch team aligned](https://www.tribecaknowledge.com/blog/how-to-keep-your-global-and-country-launch-team-aligned) With the right digital technology, your launch team can work together to ensure global strategies are leveraged optimally in challenging local environments. [Read more](https://www.tribecaknowledge.com/blog/how-to-keep-your-global-and-country-launch-team-aligned) ### [The Ultimate Guide to Launch Readiness in 2019](https://www.tribecaknowledge.com/blog/the-ultimate-guide-to-launch-readiness-in-2019) Pharmaceutical companies must embrace pioneering new product launch software if they really want to optimise launch readiness to capitalise on renewed innovation and R&D productivity. [Read more](https://www.tribecaknowledge.com/blog/the-ultimate-guide-to-launch-readiness-in-2019) ### [6 pharma trends for 2019 that will set the pace for industry](https://www.tribecaknowledge.com/blog/top-6-pharma-trends-for-2019-that-will-set-the-pace-for-industry) We take a look at the Top 6 Pharma Trends for 2019: From slowing sales growth, biosimilars getting serious, growing pressure on US pricing, more Brexit uncertainty, value focused R&D to the need to address the industry’s ‘me-too’ deficit. [Read more](https://www.tribecaknowledge.com/blog/top-6-pharma-trends-for-2019-that-will-set-the-pace-for-industry) ### [Getting your launch strategy right for today’s market access paradigm](https://www.tribecaknowledge.com/blog/getting-your-launch-strategy-right-for-todays-market-access-paradigm) Today’s launch strategies are more modestly scaled, but they must be planned, implemented and tracked in greater depth. [Read more](https://www.tribecaknowledge.com/blog/getting-your-launch-strategy-right-for-todays-market-access-paradigm) ### [Pharma launch challenges will only get worse](https://www.tribecaknowledge.com/blog/pharma-launch-challenges-will-only-get-worse) There is plenty of pharmaceutical innovation left in the tank, judging by current product pipelines. Pharma launch challenges, though, have never been tougher. [Read more](https://www.tribecaknowledge.com/blog/pharma-launch-challenges-will-only-get-worse) ### Recent Posts - [2025 New Drug Approvals: Key FDA and EMA approvals and Emerging Trends](https://www.tribecaknowledge.com/blog/2025-new-drug-approvals-key-fda-and-ema-approvals-and-emerging-trends) - [Driving launch excellence with agile transformation](https://www.tribecaknowledge.com/blog/driving-launch-excellence-with-agile-transformation) - [Launch Readiness 2025: What this year holds in store for pharma product launches](https://www.tribecaknowledge.com/blog/launch-readiness-2025-what-this-year-holds-in-store-for-pharma-product-launches) - [6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges) - [2024 New Drug Approvals: Key FDA and EMA approvals, breakthroughs and market trends](https://www.tribecaknowledge.com/blog/2024-new-drug-approvals-key-fda-and-ema-approvals-breakthroughs-and-market-trends) ### Most Popular Posts - [2025 New Drug Approvals: Key FDA and EMA approvals and Emerging Trends](https://www.tribecaknowledge.com/blog/2025-new-drug-approvals-key-fda-and-ema-approvals-and-emerging-trends) - [What Pfizer’s digital transformation strategy can teach us about making pharma more agile and effective](https://www.tribecaknowledge.com/blog/what-pfizers-digital-transformation-strategy-can-teach-us-about-making-pharma-more-agile-and-effective) - [2024 New Drug Approvals: Key FDA and EMA approvals, breakthroughs and market trends](https://www.tribecaknowledge.com/blog/2024-new-drug-approvals-key-fda-and-ema-approvals-breakthroughs-and-market-trends) - [6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges) - [Market Access 2025: Navigating the emerging HTA and drug reimbursement challenges](https://www.tribecaknowledge.com/blog/market-access-2025-new-report-on-navigating-the-emerging-hta-and-drug-reimbursement-challenges) ### Categories - [launch readiness](https://www.tribecaknowledge.com/blog/topic/launch-readiness) - [Market access](https://www.tribecaknowledge.com/blog/topic/market-access) - [Pharma trends](https://www.tribecaknowledge.com/blog/topic/pharma-trends) - [Pharma launch planning](https://www.tribecaknowledge.com/blog/topic/pharma-launch-planning) - [launch plan](https://www.tribecaknowledge.com/blog/topic/launch-plan) - [launch readiness framework](https://www.tribecaknowledge.com/blog/topic/launch-readiness-framework) - [launch effectiveness](https://www.tribecaknowledge.com/blog/topic/launch-effectiveness) - [launch strategy](https://www.tribecaknowledge.com/blog/topic/launch-strategy) - [Tender Management](https://www.tribecaknowledge.com/blog/topic/tender-management) #### Get our latest posts in your inbox TRiBECA Knowledge needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.